AIM ImmunoTech Inc. has signed an agreement to plan a proposed Phase III clinical trial of its core candidate drug Ampligen for the treatment of advanced pancreatic cancer.

老虎证券2026/03/02 14:13

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

This move marks a critical step for the company in advancing the clinical development of this immunotherapy for this hard-to-treat cancer.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Alphabet has issued euro-denominated bonds for the second time this year, across seven tranches with maturities ranging from 2 to 19 years. Concerns over AI spending have widened credit spreads, and credit default swap contracts surged by 6.4 basis points in a single day to nearly 91 basis points, reaching a historic high.

智通财经•2026/11/02 08:46